Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Student Scientific Society, Department of Biophysics, Jagiellonian University Medical College, Kraków, Poland.
Front Endocrinol (Lausanne). 2021 Aug 27;12:722199. doi: 10.3389/fendo.2021.722199. eCollection 2021.
Turner syndrome (TS) presents a high risk of congenital heart defects and may predispose to both obesity and related metabolic complications. Hence the search for new markers as potential early predictors of the metabolic syndrome (MetS) and cardiovascular diseases appears warranted.
To assess MMP-1 (matrix metalloproteinase-1), MMP-2 (matrix metalloproteinase-2), MMP-9 (matrix metallopeptidase-9), BDNF (brain-derived neurotrophic factor), GDNF (glial cell line-derived neurotrophic factor), and VEGF (vascular endothelial growth factor) in non-MetS TS girls not treated with growth hormone (GH) . healthy short stature girls, and to assess the connection with basic metabolic parameters.
The concentrations of circulating MMP-1, MMP-2, MMP-9, BDNF, GDNF and VEGF were measured in 12 patients with TS not treated with growth hormone. The control group was composed of 17 girls with non-pathologic short stature. The patients' clinical and biochemical phenotypes were determined by weight, height, total cholesterol, HDL cholesterol, triglycerides, glucose, aminotransferases, IGF1, TSH and fT4.
There were no differences in mean age, weight, BMI Z-Score, or hSDS between the studied group and the controls; however, they differed in baseline values of ALT (18.2 ± 4.2 . 14.2 ± 4.1, p= 0.02), BDNF [29951.5 (26176.9 - 41271.9) . 23131.7 (18392.4 - 28313.3), p=0.01] and MMP-2 [91.8 (71.7 - 111.0) . 143.6 (123.7 - 244.5), p< 0.001]. BDNF correlated with ALT activity (r = 0.56 p = 0.002) and BMI Z-score (r = 0.38 p = 0.042), while MMP-2 correlated with HDL concentration (r = 0.48 p = 0.029) in all the patients. The analysis of the study group alone revealed significant positive correlations between MMP-9 and TSH (r = 0.74 p = 0.036), BDNF and both ALT (r = 0.73 p = 0.038) and TSH (r = 0.85 p = 0.008), and a negative correlation between MMP-1 and fT4 (r = -0.75 p = 0.032). The control group did not present any significant correlations.
The higher concentrations of BDNF and lower of MMP-2 found in girls with TS without MetS compared to healthy girls with short stature, could have a major impact on the future "natural" development of the metabolic status. Our findings need further studies.
特纳综合征(TS)存在先天性心脏病的高风险,并且可能导致肥胖和相关代谢并发症。因此,寻找新的标志物作为代谢综合征(MetS)和心血管疾病的潜在早期预测因子似乎是合理的。
评估未接受生长激素(GH)治疗的非 MetS TS 女孩、健康矮小女孩的 MMP-1(基质金属蛋白酶-1)、MMP-2(基质金属蛋白酶-2)、MMP-9(基质金属肽酶-9)、BDNF(脑源性神经营养因子)、GDNF(胶质细胞系衍生的神经营养因子)和 VEGF(血管内皮生长因子)的浓度,并评估其与基本代谢参数的关系。
测量了 12 名未接受生长激素治疗的 TS 患者的循环 MMP-1、MMP-2、MMP-9、BDNF、GDNF 和 VEGF 浓度。对照组由 17 名非病理性矮小的女孩组成。通过体重、身高、总胆固醇、HDL 胆固醇、甘油三酯、葡萄糖、氨基转移酶、IGF1、TSH 和 fT4 来确定患者的临床和生化表型。
研究组与对照组的平均年龄、体重、BMI Z 评分或 hSDS 无差异;然而,两组在 ALT 基线值[18.2 ± 4.2 vs. 14.2 ± 4.1,p=0.02]、BDNF [29951.5(26176.9-41271.9)vs. 23131.7(18392.4-28313.3),p=0.01]和 MMP-2 [91.8(71.7-111.0)vs. 143.6(123.7-244.5),p<0.001]方面存在差异。BDNF 与 ALT 活性(r=0.56,p=0.002)和 BMI Z 评分(r=0.38,p=0.042)相关,而 MMP-2 与所有患者的 HDL 浓度(r=0.48,p=0.029)相关。对研究组的单独分析显示,MMP-9 与 TSH 之间存在显著正相关(r=0.74,p=0.036),BDNF 与 ALT(r=0.73,p=0.038)和 TSH(r=0.85,p=0.008)之间存在显著正相关,MMP-1 与 fT4 之间存在显著负相关(r=-0.75,p=0.032)。对照组未出现任何显著相关性。
与健康矮小的女孩相比,未接受 MetS 治疗的 TS 女孩中较高的 BDNF 浓度和较低的 MMP-2 浓度可能对未来的代谢状态“自然”发展有重大影响。我们的发现需要进一步研究。